We are live on ! Find out more
PCM

Poehling Capital Management Portfolio holdings

AUM $466M
1-Year Est. Return 24.17%
This Fund
S&P 500
This Quarter Est. Return
+11.58%
1 Year Est. Return
+24.17%
3 Year Est. Return
+70.93%
5 Year Est. Return
+69.6%
10 Year Est. Return
AUM
$267M
AUM Growth
+$28.4M
Cap. Flow
+$4.64M
Cap. Flow %
1.74%
Top 10 Hldgs %
33.54%
Holding
127
New
15
Increased
39
Reduced
49
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 34.17%
2 Healthcare 20.43%
3 Communication Services 8.53%
4 Technology 7.66%
5 Energy 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRNE
126
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-16,000
Closed -$25K
CLR
127
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-28,941
Closed -$1.93M

Similar funds

Poehling Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Poehling Capital Management held 127 positions worth $267M, up 12% from $239M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Poehling Capital Management's Q4 2022 filing shows 15 new, 39 increased, 49 reduced and 6 closed positions. Its largest new stake was HF Sinclair: 34,730 shares worth $1.8M. The largest sale was Amgen, an estimated $3.54M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 31% a quarter earlier, followed by Healthcare and Communication Services.

  • Poehling Capital Management's largest Q4 2022 buy was HF Sinclair: 34,730 shares worth $1.8M.
  • Poehling Capital Management added most to Medtronic in Q4 2022, an estimated $4.43M increase.
  • Poehling Capital Management's biggest Q4 2022 reduction was Amgen, cutting an estimated $3.54M.
  • Poehling Capital Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $1.93M.
  • Poehling Capital Management's ten largest holdings make up 34% of its $267M portfolio in Q4 2022.
  • Poehling Capital Management opened 15 new positions and closed 6 in Q4 2022.
  • Poehling Capital Management's portfolio value rose 12% quarter-over-quarter to $267M.

Based on Poehling Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.